Current costs of dialysis modalities: A comprehensive analysis within the United Kingdom.

Gareth Roberts, Jennifer Holmes, Gail Williams, James Chess, Ned Hartfiel, Joanna M Charles, Leah McLauglin, Jane Noyes, Rhiannon Tudor Edwards
{"title":"Current costs of dialysis modalities: A comprehensive analysis within the United Kingdom.","authors":"Gareth Roberts, Jennifer Holmes, Gail Williams, James Chess, Ned Hartfiel, Joanna M Charles, Leah McLauglin, Jane Noyes, Rhiannon Tudor Edwards","doi":"10.1177/08968608211061126","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Previous evidence suggests home-based dialysis to be more cost-effective than unit-based or hospital-based dialysis. However, previous analyses to quantify the costs of different dialysis modalities have used varied perspectives, different methods, and required assumptions due to lack of available data. The National Institute for Health and Care Excellence reports uncertainty about the differences in costs between home-based and unit-based dialysis. This uncertainty limits the ability of policy makers to make recommendations based on cost effectiveness, which also impacts on the ability of budget holders to model the impact of any service redesign and to understand which therapies deliver better value. The aim of our study was to use a combination of top-down and bottom-up costing methods to determine the direct medical costs of different dialysis modalities in one UK nation (Wales) from the perspective of the National Health Service (NHS).</p><p><strong>Methods: </strong>Detailed hybrid top-down and bottom-up micro-costing methods were applied to estimate the direct medical costs of dialysis modalities across Wales. Micro-costing data was obtained from commissioners of the service and from interviews with renal consultants, nurses, accountants, managers and allied health professionals. Top-down costing information was obtained from the Welsh Renal Clinical Network (who commission renal services across Wales) and the Welsh Ambulance Service Trust.</p><p><strong>Results: </strong>The annual direct cost per patient for home-based modalities was £16,395 for continuous ambulatory peritoneal dialysis (CAPD), £20,295 for automated peritoneal dialysis (APD) and £23,403 for home-based haemodialysis (HHD). The annual cost per patient for unit-based modalities depended on whether or not patients required ambulance transport. Excluding transport, the cost of dialysis was £19,990 for satellite units run in partnership with independent sector providers and £23,737 for hospital units managed and staffed by the NHS. When ambulance transport was included, the respective costs were £28,931 and £32,678, respectively.</p><p><strong>Conclusion: </strong>Our study is the most comprehensive analysis of the costs of dialysis undertaken thus far in the United Kingdom and clearly demonstrate that CAPD is less costly than other dialysis modalities. When ambulance transport costs are included, other home therapies (APD and HHD) are also less costly than unit-based dialysis. This detailed analysis of the components that contribute to dialysis costs will help inform future cost-effectiveness studies, inform healthcare policy and drive service redesign.</p>","PeriodicalId":519220,"journal":{"name":"Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis","volume":" ","pages":"578-584"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/08968608211061126","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/24 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Previous evidence suggests home-based dialysis to be more cost-effective than unit-based or hospital-based dialysis. However, previous analyses to quantify the costs of different dialysis modalities have used varied perspectives, different methods, and required assumptions due to lack of available data. The National Institute for Health and Care Excellence reports uncertainty about the differences in costs between home-based and unit-based dialysis. This uncertainty limits the ability of policy makers to make recommendations based on cost effectiveness, which also impacts on the ability of budget holders to model the impact of any service redesign and to understand which therapies deliver better value. The aim of our study was to use a combination of top-down and bottom-up costing methods to determine the direct medical costs of different dialysis modalities in one UK nation (Wales) from the perspective of the National Health Service (NHS).

Methods: Detailed hybrid top-down and bottom-up micro-costing methods were applied to estimate the direct medical costs of dialysis modalities across Wales. Micro-costing data was obtained from commissioners of the service and from interviews with renal consultants, nurses, accountants, managers and allied health professionals. Top-down costing information was obtained from the Welsh Renal Clinical Network (who commission renal services across Wales) and the Welsh Ambulance Service Trust.

Results: The annual direct cost per patient for home-based modalities was £16,395 for continuous ambulatory peritoneal dialysis (CAPD), £20,295 for automated peritoneal dialysis (APD) and £23,403 for home-based haemodialysis (HHD). The annual cost per patient for unit-based modalities depended on whether or not patients required ambulance transport. Excluding transport, the cost of dialysis was £19,990 for satellite units run in partnership with independent sector providers and £23,737 for hospital units managed and staffed by the NHS. When ambulance transport was included, the respective costs were £28,931 and £32,678, respectively.

Conclusion: Our study is the most comprehensive analysis of the costs of dialysis undertaken thus far in the United Kingdom and clearly demonstrate that CAPD is less costly than other dialysis modalities. When ambulance transport costs are included, other home therapies (APD and HHD) are also less costly than unit-based dialysis. This detailed analysis of the components that contribute to dialysis costs will help inform future cost-effectiveness studies, inform healthcare policy and drive service redesign.

透析方式的当前成本:英国的综合分析。
背景:先前的证据表明,家庭透析比单位或医院透析更具成本效益。然而,由于缺乏可用数据,以往量化不同透析方式成本的分析使用了不同的视角、不同的方法和需要的假设。国家健康和护理卓越研究所报告了家庭透析和单位透析之间成本差异的不确定性。这种不确定性限制了政策制定者根据成本效益提出建议的能力,这也影响了预算持有人对任何服务重新设计的影响进行建模的能力,以及了解哪种治疗方法能带来更好的价值。我们研究的目的是从国民健康服务(NHS)的角度出发,结合自上而下和自下而上的成本计算方法来确定一个英国国家(威尔士)不同透析方式的直接医疗成本。方法:详细混合自上而下和自下而上的微观成本计算方法被应用于估计整个威尔士的透析方式的直接医疗费用。微观成本计算数据是从该服务的专员和对肾脏顾问、护士、会计、管理人员和专职保健专业人员的访谈中获得的。自上而下的成本信息是从威尔士肾脏临床网络(委托威尔士各地的肾脏服务)和威尔士救护车服务信托基金获得的。结果:以家庭为基础的方式,每位患者的年度直接成本为连续动态腹膜透析(CAPD) 16,395英镑,自动腹膜透析(APD) 20,295英镑,家庭血液透析(HHD) 23,403英镑。以单位为基础的模式的每位患者的年费用取决于患者是否需要救护车运输。不包括运输费用,与独立部门供应商合作经营的卫星单位的透析费用为19,990英镑,由国民保健制度管理和配备人员的医院单位的透析费用为23,737英镑。如果包括救护车运输,费用分别为28,931英镑和32,678英镑。结论:我们的研究是迄今为止在英国进行的透析成本最全面的分析,并清楚地表明CAPD比其他透析方式成本更低。如果包括救护车运输费用,其他家庭治疗(APD和HHD)也比单位透析更便宜。对导致透析成本的组成部分的详细分析将有助于为未来的成本效益研究提供信息,为医疗保健政策提供信息,并推动服务重新设计。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信